Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTC844 in Active Rheumatoid Arthritis
NCT07779616Phase 2Not yet recruiting
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Aug 2026
- Primary completion
- Sep 2027
01
Overview
A Phase 2 trial of PTC844 in rheumatoid arthritis (RA), sponsored by PTC Therapeutics, Inc.. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
PTC844
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07779616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07779616.